Adynxx (OTCMKTS:ADYX – Get Rating) and KORU Medical Systems (NASDAQ:KRMD – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends and earnings.
Analyst Recommendations
This is a breakdown of recent ratings and target prices for Adynxx and KORU Medical Systems, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Adynxx | 0 | 0 | 0 | 0 | N/A |
KORU Medical Systems | 0 | 0 | 3 | 0 | 3.00 |
KORU Medical Systems has a consensus target price of $4.17, indicating a potential upside of 5.22%.
Valuation & Earnings
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Adynxx | N/A | N/A | N/A | N/A | N/A |
KORU Medical Systems | $29.04 million | 6.22 | -$8.66 million | ($0.19) | -20.84 |
Adynxx has higher earnings, but lower revenue than KORU Medical Systems.
Volatility and Risk
Adynxx has a beta of 2.81, indicating that its share price is 181% more volatile than the S&P 500. Comparatively, KORU Medical Systems has a beta of 0.4, indicating that its share price is 60% less volatile than the S&P 500.
Profitability
This table compares Adynxx and KORU Medical Systems’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Adynxx | N/A | N/A | N/A |
KORU Medical Systems | -29.39% | -26.19% | -19.95% |
Insider & Institutional Ownership
36.1% of KORU Medical Systems shares are owned by institutional investors. 17.4% of Adynxx shares are owned by insiders. Comparatively, 25.6% of KORU Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
About Adynxx
Adynxx, Inc. is a clinical stage biopharmaceutical company. It engages in the manufacture, development, and sale of novel, disease-modifying products for the treatment of pain and inflammation. The company was founded by Julien Mamet in October, 2007 and is headquartered in San Francisco, CA.
About KORU Medical Systems
KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. Its product portfolio includes FREEDOM60, FreedomEdge syringe drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Mahwah, NJ.
Receive News & Ratings for Adynxx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adynxx and related companies with MarketBeat.com's FREE daily email newsletter.